Brought to you by 
J&J agrees to acquire Alza for stock
30 Apr 2001
Executive Summary
Johnson & Johnson has agreed to acquire drug delivery company Alza in a tax-free pooling of interests. Based on J&J's pre-announcement trading average of $90.41 per share, the transaction would be worth a total of $13.1bn.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com